ÀÇ·áÁø ã±â
¾Æ·¡ °Ë»öÀ» ÅëÇØ Á¤È®ÇÏ°í ºü¸£°Ô ÀÇ·áÁøÀ» °Ë»öÇÒ ¼ö ÀÖ½À´Ï´Ù.
Ŭ¸®´Ð ¾È³»
Ŭ¸®´ÐÀ» ¾È³»ÇØ µå¸³´Ï´Ù. Ŭ¸¯ ½Ã ÇØ´ç Ŭ¸®´ÐÀÇ ÀÚ¼¼ÇÑ »çÇ×À» º¸½Ç ¼ö ÀÖ½À´Ï´Ù.
°ü»óµ¿¸ÆÁúȯ
-
[SCI]
A relationship between unrecognized anaemia and the development of type 2 diabetes mellitus in patient with cardiovascular risks.
Choi BG, Kim JB, Rha SW, Kim SW, Lee MW, Lee MS, Choi SY, Byun JK, Cha J, Na JO, Choi CU, Park CG, Seo HS, Oh DJ, Hong S.
/ A relationship between unrecognized anaemia and the development of type 2 diabetes mellitus in patient with cardiovascular risks.
/ 2021 Apr;48(4):455-462.
/ 202104
-
[SCI]
Initial diastolic dysfunction is a powerful predictor of 5-year mortality in peripheral arterial disease patients undergoing percutaneous transluminal angioplasty.
Kim KH, Vallabhajosyula S, Rha SW, Choi BG, Byun JK, Choi CU.
/ Initial diastolic dysfunction is a powerful predictor of 5-year mortality in peripheral arterial disease patients undergoing percutaneous transluminal angioplasty.
/ 2021 Mar 9
/ 202103
-
[±¹¿Ü³í¹®]
Impact of Sleep-Disordered Breathing on Functional Outcomes in Ischemic Stroke: A Cardiopulmonary Coupling Analysis
/ Impact of Sleep-Disordered Breathing on Functional Outcomes in Ischemic Stroke: A Cardiopulmonary Coupling Analysis
/ Volume 51, Issue 7, July 2020;, Pages 2188-2196
/ 202007
-
[±¹³»³í¹®]
Pharmacological Strategies beyond Statins: Ezetimibe and PCSK9 Inhibitors.
/ Pharmacological Strategies beyond Statins: Ezetimibe and PCSK9 Inhibitors.
/ 2019 Sep;8(2):183-191.
/ 201909
-
[±¹³»³í¹®]
2018 Guidelines for the management of dyslipidemia.
/ 2018 Guidelines for the management of dyslipidemia.
/ 2019 Jul;34(4):723-771. doi: 10.3904/kjim.2019.188. Epub 2019 Jul 1.
/ 201907